Hemoccult Sensa 15 mL Developer Solution

• Rapid fecal occult blood identification
• Qualitative approach for GI complications
• Does not diagnose colorectal cancer
• Improved readability and sensitivity
• 92% accuracy rate
• Crucial for detecting true positives
• Pivotal in global cancer screening
• Sold as a Single Piece
  

Description

The Hemoccult II SENSA test presents a rapid and qualitative approach to identifying fecal occult blood, often a sign of gastrointestinal complications. It’s essential to note that this test does not specifically diagnose colorectal cancer but offers an efficient means to detect gastrointestinal issues.

Hemoccult II SENSA outperforms other FOBTs by improving readability and enhancing clinical sensitivity, delivering a staggering 92% accuracy rate. This high sensitivity enables the discovery of more true positives of occult blood, crucial for identifying intermittent bleeding from polyps and cancer.

Its comprehensive support system and 14-day stability on-slide make it a pivotal element in colorectal cancer screening programs globally, offering patients and clinicians vital insights for early detection and intervention.